Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1998-01-29
1999-12-14
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
A67K 3124
Patent
active
060018755
ABSTRACT:
The present invention is directed to the prevention in vivo of the nonenzymatic glycation of albumin, which generates biologically active Amadori glucose adducts in the albumin molecule, as well as methods of using compounds that protect against nonenzymatic glycation in vivo to treat kidney dysfunction.
REFERENCES:
patent: 4060626 (1977-11-01), Hrstka et al.
patent: 5245046 (1993-09-01), Youngdale et al.
EMbase Abstract 92126412 (1992) .cndot.van Boekel et al, 1992.
Clements Rex
Cohen Margo P.
Exocell Inc.
Fay Zohreh
LandOfFree
In vivo methods of treatment to prevent kidney dysfunction using does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with In vivo methods of treatment to prevent kidney dysfunction using, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vivo methods of treatment to prevent kidney dysfunction using will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863931